1. Home
  2. MRVI vs PML Comparison

MRVI vs PML Comparison

Compare MRVI & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.61

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Logo Pimco Municipal Income Fund II of Beneficial Interest

PML

Pimco Municipal Income Fund II of Beneficial Interest

HOLD

Current Price

$7.57

Market Cap

502.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
PML
Founded
2014
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
449.6M
502.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MRVI
PML
Price
$3.61
$7.57
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$4.58
N/A
AVG Volume (30 Days)
1.5M
188.0K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
5.65%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$192,435,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$6.92
52 Week High
$6.21
$9.46

Technical Indicators

Market Signals
Indicator
MRVI
PML
Relative Strength Index (RSI) 54.00 29.60
Support Level $3.50 $7.53
Resistance Level $3.95 $7.68
Average True Range (ATR) 0.18 0.05
MACD -0.01 -0.01
Stochastic Oscillator 46.46 14.55

Price Performance

Historical Comparison
MRVI
PML

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About PML Pimco Municipal Income Fund II of Beneficial Interest

PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.

Share on Social Networks: